Prevention of nausea and vomiting following breast surgery

Rakhshanda Layeeque, Eric Siegel, Rena Kass, Ronda S. Henry-Tillman, Maureen Colvert, Anne Mancino, Vicki Klimberg

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: The purpose of this study was to determine the rate of nausea and vomiting in women following breast surgery (PONV) under general anesthesia (GA), before and after the introduction of a standardized prophylactic anti-emetic (AE) regimen. Methods: We performed a retrospective review of eligible patients, between July 2001 and March 2003. Patients operated on before September 2002 had standard preoperative care (old cohort [OC]); patients operated on after September 2002 were treated prophylactically with oral dronabinol 5 mg and rectal prochlorperazine 25 mg (new cohort [NC]). Data were collected from hospital records regarding age, diagnosis, comorbid conditions, previous anesthesia history, anesthesia and operative details, episodes PONV, and use of AE. The rate and severity of PONV was calculated for both cohorts. Results: Two hundred forty-two patients were studied: 127 patients in the OC and 115 patients in the NC. The median age was 56 years (range 32 to 65). The rate of nausea and vomiting were significantly better in the patients treated prophylactically with dronabinol and prochlorperazine (59% vs. 15%, P < .0001 and 29% vs. 3%, P < .0001). Twenty patients in the OC were given some prophylactic AE treatment and 12 (60%) of them required further treatment; only 12 of 109 patients (11%) in the NC required further AE treatment (P < .0001). Conclusion: PONV is a significant problem in breast surgical patients. Preoperative treatment with dronabinol and prochlorperazine significantly reduced the number and severity of episodes of PONV.

Original languageEnglish (US)
Pages (from-to)767-772
Number of pages6
JournalAmerican Journal of Surgery
Volume191
Issue number6
DOIs
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Nausea
Vomiting
Breast
Postoperative Nausea and Vomiting
Antiemetics
Prochlorperazine
Dronabinol
Anesthesia
Preoperative Care
Hospital Records
Therapeutics
General Anesthesia
History

Keywords

  • Ambulatory surgery
  • Breast surgery
  • Postoperative nausea and vomiting

ASJC Scopus subject areas

  • Surgery

Cite this

Layeeque, R., Siegel, E., Kass, R., Henry-Tillman, R. S., Colvert, M., Mancino, A., & Klimberg, V. (2006). Prevention of nausea and vomiting following breast surgery. American Journal of Surgery, 191(6), 767-772. https://doi.org/10.1016/j.amjsurg.2005.07.040

Prevention of nausea and vomiting following breast surgery. / Layeeque, Rakhshanda; Siegel, Eric; Kass, Rena; Henry-Tillman, Ronda S.; Colvert, Maureen; Mancino, Anne; Klimberg, Vicki.

In: American Journal of Surgery, Vol. 191, No. 6, 06.2006, p. 767-772.

Research output: Contribution to journalArticle

Layeeque, R, Siegel, E, Kass, R, Henry-Tillman, RS, Colvert, M, Mancino, A & Klimberg, V 2006, 'Prevention of nausea and vomiting following breast surgery', American Journal of Surgery, vol. 191, no. 6, pp. 767-772. https://doi.org/10.1016/j.amjsurg.2005.07.040
Layeeque R, Siegel E, Kass R, Henry-Tillman RS, Colvert M, Mancino A et al. Prevention of nausea and vomiting following breast surgery. American Journal of Surgery. 2006 Jun;191(6):767-772. https://doi.org/10.1016/j.amjsurg.2005.07.040
Layeeque, Rakhshanda ; Siegel, Eric ; Kass, Rena ; Henry-Tillman, Ronda S. ; Colvert, Maureen ; Mancino, Anne ; Klimberg, Vicki. / Prevention of nausea and vomiting following breast surgery. In: American Journal of Surgery. 2006 ; Vol. 191, No. 6. pp. 767-772.
@article{666b1971eaa44951a0d9ef4b5aac967e,
title = "Prevention of nausea and vomiting following breast surgery",
abstract = "Background: The purpose of this study was to determine the rate of nausea and vomiting in women following breast surgery (PONV) under general anesthesia (GA), before and after the introduction of a standardized prophylactic anti-emetic (AE) regimen. Methods: We performed a retrospective review of eligible patients, between July 2001 and March 2003. Patients operated on before September 2002 had standard preoperative care (old cohort [OC]); patients operated on after September 2002 were treated prophylactically with oral dronabinol 5 mg and rectal prochlorperazine 25 mg (new cohort [NC]). Data were collected from hospital records regarding age, diagnosis, comorbid conditions, previous anesthesia history, anesthesia and operative details, episodes PONV, and use of AE. The rate and severity of PONV was calculated for both cohorts. Results: Two hundred forty-two patients were studied: 127 patients in the OC and 115 patients in the NC. The median age was 56 years (range 32 to 65). The rate of nausea and vomiting were significantly better in the patients treated prophylactically with dronabinol and prochlorperazine (59{\%} vs. 15{\%}, P < .0001 and 29{\%} vs. 3{\%}, P < .0001). Twenty patients in the OC were given some prophylactic AE treatment and 12 (60{\%}) of them required further treatment; only 12 of 109 patients (11{\%}) in the NC required further AE treatment (P < .0001). Conclusion: PONV is a significant problem in breast surgical patients. Preoperative treatment with dronabinol and prochlorperazine significantly reduced the number and severity of episodes of PONV.",
keywords = "Ambulatory surgery, Breast surgery, Postoperative nausea and vomiting",
author = "Rakhshanda Layeeque and Eric Siegel and Rena Kass and Henry-Tillman, {Ronda S.} and Maureen Colvert and Anne Mancino and Vicki Klimberg",
year = "2006",
month = "6",
doi = "10.1016/j.amjsurg.2005.07.040",
language = "English (US)",
volume = "191",
pages = "767--772",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Prevention of nausea and vomiting following breast surgery

AU - Layeeque, Rakhshanda

AU - Siegel, Eric

AU - Kass, Rena

AU - Henry-Tillman, Ronda S.

AU - Colvert, Maureen

AU - Mancino, Anne

AU - Klimberg, Vicki

PY - 2006/6

Y1 - 2006/6

N2 - Background: The purpose of this study was to determine the rate of nausea and vomiting in women following breast surgery (PONV) under general anesthesia (GA), before and after the introduction of a standardized prophylactic anti-emetic (AE) regimen. Methods: We performed a retrospective review of eligible patients, between July 2001 and March 2003. Patients operated on before September 2002 had standard preoperative care (old cohort [OC]); patients operated on after September 2002 were treated prophylactically with oral dronabinol 5 mg and rectal prochlorperazine 25 mg (new cohort [NC]). Data were collected from hospital records regarding age, diagnosis, comorbid conditions, previous anesthesia history, anesthesia and operative details, episodes PONV, and use of AE. The rate and severity of PONV was calculated for both cohorts. Results: Two hundred forty-two patients were studied: 127 patients in the OC and 115 patients in the NC. The median age was 56 years (range 32 to 65). The rate of nausea and vomiting were significantly better in the patients treated prophylactically with dronabinol and prochlorperazine (59% vs. 15%, P < .0001 and 29% vs. 3%, P < .0001). Twenty patients in the OC were given some prophylactic AE treatment and 12 (60%) of them required further treatment; only 12 of 109 patients (11%) in the NC required further AE treatment (P < .0001). Conclusion: PONV is a significant problem in breast surgical patients. Preoperative treatment with dronabinol and prochlorperazine significantly reduced the number and severity of episodes of PONV.

AB - Background: The purpose of this study was to determine the rate of nausea and vomiting in women following breast surgery (PONV) under general anesthesia (GA), before and after the introduction of a standardized prophylactic anti-emetic (AE) regimen. Methods: We performed a retrospective review of eligible patients, between July 2001 and March 2003. Patients operated on before September 2002 had standard preoperative care (old cohort [OC]); patients operated on after September 2002 were treated prophylactically with oral dronabinol 5 mg and rectal prochlorperazine 25 mg (new cohort [NC]). Data were collected from hospital records regarding age, diagnosis, comorbid conditions, previous anesthesia history, anesthesia and operative details, episodes PONV, and use of AE. The rate and severity of PONV was calculated for both cohorts. Results: Two hundred forty-two patients were studied: 127 patients in the OC and 115 patients in the NC. The median age was 56 years (range 32 to 65). The rate of nausea and vomiting were significantly better in the patients treated prophylactically with dronabinol and prochlorperazine (59% vs. 15%, P < .0001 and 29% vs. 3%, P < .0001). Twenty patients in the OC were given some prophylactic AE treatment and 12 (60%) of them required further treatment; only 12 of 109 patients (11%) in the NC required further AE treatment (P < .0001). Conclusion: PONV is a significant problem in breast surgical patients. Preoperative treatment with dronabinol and prochlorperazine significantly reduced the number and severity of episodes of PONV.

KW - Ambulatory surgery

KW - Breast surgery

KW - Postoperative nausea and vomiting

UR - http://www.scopus.com/inward/record.url?scp=33646723051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646723051&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2005.07.040

DO - 10.1016/j.amjsurg.2005.07.040

M3 - Article

VL - 191

SP - 767

EP - 772

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 6

ER -